Travoprost FDA approval date

The FDA approved Travoprost on 16 Mar 2001.

FDA approval date
16 Mar 2001

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Exchange of Travoprost Intraocular ImplantNCT04615403Glaukos CorporationPhase 2Completed2022-02-28Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2001-03-16DayTravoprostFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021257", "applicant_as_listed_by_fda": "ALCON PHARMS LTD", "brand_names": ["TRAVATAN"], "active_ingredients": ["TRAVOPROST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20010316", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026